MADCAM1
Mucosal addressin cell adhesion molecule 1
Also known as: MACAM1, MADCA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13477
- Gene
- MADCAM1
- Ensembl
- ENSG00000099866
- Chromosome
- 19
- Canonical length
- 382 aa
- Protein class
- Predicted membrane proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is an endothelial cell adhesion molecule that interacts preferentially with the leukocyte beta7 integrin LPAM-1 (alpha4beta7), L-selectin, and VLA-4 (alpha4beta1) on myeloid cells to direct leukocytes into mucosal and inflamed tissues. It is a member of the immunoglobulin family and is similar to ICAM1 and VCAM1. At least seven alternatively spliced transcripts encoding different protein isoforms have been found for this gene, but the full-length nature of some variants has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
382 residues, UniProt reviewed canonical sequence.
>Q13477|MADCAM1
1 MDFGLALLLA GLLGLLLGQS LQVKPLQVEP PEPVVAVALG ASRQLTCRLA CADRGASVQW
61 RGLDTSLGAV QSDTGRSVLT VRNASLSAAG TRVCVGSCGG RTFQHTVQLL VYAFPDQLTV
121 SPAALVPGDP EVACTAHKVT PVDPNALSFS LLVGGQELEG AQALGPEVQE EEEEPQGDED
181 VLFRVTERWR LPPLGTPVPP ALYCQATMRL PGLELSHRQA IPVLHSPTSP EPPDTTSPES
241 PDTTSPESPD TTSQEPPDTT SPEPPDKTSP EPAPQQGSTH TPRSPGSTRT RRPEISQAGP
301 TQGEVIPTGS SKPAGDQLPA ALWTSSAVLG LLLLALPTYH LWKRCRHLAE DDTHPPASLR
361 LLPQVSAWAG LRGTGQVGIS PSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MADCAM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- appendix: 13 nTPM
- small intestine: 12 nTPM
- spleen: 8.1 nTPM
- colon: 6.8 nTPM
- cerebellum: 5.6 nTPM
- cerebral cortex: 4.9 nTPM
Single-cell type
- bergmann glia: 26 nCPM
- neutrophils: 24 nCPM
- astrocytes: 23 nCPM
- epididymal principal cells: 21 nCPM
- müller glia: 20 nCPM
- oligodendrocytes: 20 nCPM
Immune cell
- neutrophil: 7 nTPM
- eosinophil: 0.8 nTPM
- naive CD4 T-cell: 0.7 nTPM
- naive CD8 T-cell: 0.7 nTPM
- naive B-cell: 0.6 nTPM
- MAIT T-cell: 0.4 nTPM
Brain region
- cerebellum: 13 nTPM
- cerebral cortex: 13 nTPM
- white matter: 12 nTPM
- midbrain: 11 nTPM
- pons: 9.7 nTPM
- medulla oblongata: 9.1 nTPM
ReferencesPubMed · IEDB
Publications for MADCAM1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Prevention of a chronic progressive form of experimental autoimmune encephalomyelitis by an antibody against mucosal addressin cell adhesion molecule-1, given early in the course of disease progression.
2000 · Immunol Cell Biol · RCR 1 · 52 citations - Alpha4beta7 integrin/MAdCAM-1 adhesion pathway is crucial for B cell migration into pancreatic lymph nodes in nonobese diabetic mice.
2010 · J Autoimmun · RCR 0.6 · 29 citations - Antibody blockade of mucosal addressin cell adhesion molecule-1 attenuates proinflammatory activity of mesenteric lymph after hemorrhagic shock and resuscitation.
2016 · Surgery · RCR 0.2 · 4 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.74
- gnomAD pLI
- 0.53
- gnomAD missense Z
- 0.48
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell adhesion
- cell-matrix adhesion
- heterotypic cell-cell adhesion
- immune response
- integrin-mediated signaling pathway
- leukocyte tethering or rolling
- positive regulation of leukocyte migration
- positive regulation of lymphocyte migration
- receptor clustering
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin domain subtype
- Immunoglobulin-like domain
- Immunoglobulin-like fold
- Immunoglobulin-like domain superfamily
- Adhesion molecule, immunoglobulin-like
- Mucosal addressin cell adhesion molecule 1
- Adhesion molecule, immunoglobulin-like
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MADCAM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MADCAM1 as an antibody target. Whether an autoantibody or antibody against MADCAM1 could matter depends on whether native MADCAM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MADCAM1 is annotated at the cell surface, where native MADCAM1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MADCAM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...